MAPK4 predicts poor prognosis and facilitates the proliferation and migration of glioma through the AKT/mTOR pathway.
Sign Up to like & getrecommendations! Published in 2023 at "Cancer medicine"
DOI: 10.1002/cam4.5859
Abstract: Mitogenâactivated protein kinase 4 (MAPK4) is an atypical member of the mitogenâactivated protein kinase (MAPK) family. We report here that MAPK4 is overexpressed in glioma. The clinical significance, biological roles and underlying molecular mechanisms through… read more here.
Keywords: facilitates proliferation; mapk4 predicts; predicts poor; poor prognosis ... See more keywords